These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition. Cuffaro D; Ciccone L; Rossello A; Nuti E; Santamaria S J Med Chem; 2022 Oct; 65(20):13505-13532. PubMed ID: 36250680 [TBL] [Abstract][Full Text] [Related]
6. The C-terminal domains of ADAMTS1 contain exosites involved in its proteoglycanase activity. Minns AF; Qi Y; Yamamoto K; Lee K; Ahnström J; Santamaria S J Biol Chem; 2023 Apr; 299(4):103048. PubMed ID: 36813235 [TBL] [Abstract][Full Text] [Related]
7. A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose. Durham TB; Marimuthu J; Toth JL; Liu C; Adams L; Mudra DR; Swearingen C; Lin C; Chambers MG; Thirunavukkarasu K; Wiley MR J Med Chem; 2017 Jul; 60(13):5933-5939. PubMed ID: 28613895 [TBL] [Abstract][Full Text] [Related]
8. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT). Deng H; O'Keefe H; Davie CP; Lind KE; Acharya RA; Franklin GJ; Larkin J; Matico R; Neeb M; Thompson MM; Lohr T; Gross JW; Centrella PA; O'Donovan GK; Bedard KL; van Vloten K; Mataruse S; Skinner SR; Belyanskaya SL; Carpenter TY; Shearer TW; Clark MA; Cuozzo JW; Arico-Muendel CC; Morgan BA J Med Chem; 2012 Aug; 55(16):7061-79. PubMed ID: 22891645 [TBL] [Abstract][Full Text] [Related]
9. ADAMTS-9 in Mouse Cartilage Has Aggrecanase Activity That Is Distinct from ADAMTS-4 and ADAMTS-5. Rogerson FM; Last K; Golub SB; Gauci SJ; Stanton H; Bell KM; Fosang AJ Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699963 [TBL] [Abstract][Full Text] [Related]
10. Aggrecanase and aggrecan degradation in osteoarthritis: a review. Huang K; Wu LD J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423 [TBL] [Abstract][Full Text] [Related]
12. [Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis]. Ji Q; Zhang Q; Wang Y Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1080-4. PubMed ID: 24279019 [TBL] [Abstract][Full Text] [Related]
13. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4. Wayne GJ; Deng SJ; Amour A; Borman S; Matico R; Carter HL; Murphy G J Biol Chem; 2007 Jul; 282(29):20991-8. PubMed ID: 17470431 [TBL] [Abstract][Full Text] [Related]
14. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells. Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232 [TBL] [Abstract][Full Text] [Related]
15. Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Fosang AJ; Little CB Nat Clin Pract Rheumatol; 2008 Aug; 4(8):420-7. PubMed ID: 18577998 [TBL] [Abstract][Full Text] [Related]
16. A Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active Oligomers. Kosasih HJ; Last K; Rogerson FM; Golub SB; Gauci SJ; Russo VC; Stanton H; Wilson R; Lamande SR; Holden P; Fosang AJ J Biol Chem; 2016 Feb; 291(7):3197-208. PubMed ID: 26668318 [TBL] [Abstract][Full Text] [Related]
17. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. Verma P; Dalal K J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191 [TBL] [Abstract][Full Text] [Related]
18. Selection and characterization of DNA aptamers inhibiting a druggable target of osteoarthritis, ADAMTS-5. Yu Y; Liu M; Choi VNT; Cheung YW; Tanner JA Biochimie; 2022 Oct; 201():168-176. PubMed ID: 35700850 [TBL] [Abstract][Full Text] [Related]
19. Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis. Brebion F; Gosmini R; Deprez P; Varin M; Peixoto C; Alvey L; Jary H; Bienvenu N; Triballeau N; Blanque R; Cottereaux C; Christophe T; Vandervoort N; Mollat P; Touitou R; Leonard P; De Ceuninck F; Botez I; Monjardet A; van der Aar E; Amantini D J Med Chem; 2021 Mar; 64(6):2937-2952. PubMed ID: 33719441 [TBL] [Abstract][Full Text] [Related]
20. Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis. Tortorella MD; Malfait AM Curr Pharm Biotechnol; 2008 Feb; 9(1):16-23. PubMed ID: 18289053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]